Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) ...

Clinical study results demonstrated that CyPath® Lung had 92% sensitivity, 87% specificity and 88% accuracy in detecting lung cancer in patients at high risk for the disease who had small lung ...

REDWOOD CITY, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) ('Rezolute” or the 'Company”), a late-stage rare disease company focused on treating hypoglycemia caused by ...

A presentation slated to be shared at this week’s meeting of vaccine advisers to the US Centers for Disease Control and Prevention claimed that a study in animals suggested that use of the ...

A review on the use of the preservative thimerosal in vaccines slated to be presented on Thursday to the U.S. Centers for Disease Control and Prevention’s outside vaccine committee cites a study ...

A comprehensive study of Medicare beneficiaries aged 65 and older reveals that emergency room diagnostic errors occur in approximately 3.2% of serious medical emergencies, affecting roughly 1 in ...

Breast cancer specialists who were not associated with the study applauded the results, saying blood tests could transform the way they monitor patients.

In a comparative pilot study, the Mediterranean diet and the low FODMAP diet both provided relief for patients with IBS.

LEXINGTON, Mass. and AMSTERDAM, May 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have been present for the past month.

Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality ...

This patient’s Neuralink brain implant gets a boost from generative AI A patient who types with his brain thanks to a Neuralink implant is using AI chatbots to speed things up.